UAB Rx pharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 22,680,771 |
| 3,240,110 |
| 1,648,899 |
| 1,495,990 |
| 213,713 |
| 6.12 |
| 6.60 |
| 3,832,993 |
| 969,189 |
| 4,101 |
| 4,798,144 |
| 2023 |
|---|
| 23,350,098 |
| 3,113,346 |
| 593,879 |
| 516,487 |
| 68,865 |
| 5.49 |
| 2.21 |
| 3,849,480 |
| 1,260,767 |
| 4,064 |
| 5,102,887 |
| 2024 |
|---|
| 24,666,210 |
| 3,479,014 |
| 585,766 |
| 505,383 |
| 71,281 |
| 5.41 |
| 2.05 |
| 3,354,863 |
| 3,217,287 |
| 6,300 |
| 6,601,011 |
Register and
explore Okredo data| 2024 |
|---|
| 24,666,210 |
| 3,479,014 |
| 585,766 |
| 505,383 |
| 71,281 |
| 5.41 |
| 2.05 |
| 3,354,863 |
| 3,217,287 |
| 6,300 |
| 6,601,011 |
Register and
explore Okredo data2024
Turnover (€)
24,666,210 €
6 % *
Sales per employee (€)
3,479,014 €12 % *
Profit before tax (€)
585,766 €
-1 % *
Net Profit (€)
505,383 €-2 % *
Profit per employee (€)
71,281 €4 % *
Total profitability (%)
5.41 %-1.46 % *
Net profitability (%)
2.05 %-7.24 % *
Equity (€)
3,354,863 €-13 % *
Amounts Payable And Liabilities (€)
3,217,287 €
155 % *
Non-current Assets (€)
6,300 €55 % *
CurrentAssets (€)
6,601,011 €29 % *